Renal Denervation Systems Market by Technology (Ultrasound. RF, Microinfusion), Product (Single Electrode Catheter, Neurve Modifying Agents), Application (Heart Failure, Hypertension, Diabetes), End User (Hospitals, Ambulatory Care) - Forecasts to 2022
The global renal denervation systems market is poised to witness a steady growth during the forecast period. This is expected to be driven by major factors such as rising prevalence of hypertension, increasing geriatric population, clinical advantages such as fast recovery time with minimal complications, technological advancements to develop alternative technologies. Moreover, increasing clinical trials to validate clinical efficacy of renal denervation and cost effectiveness of the procedure over conventional surgeries are expected to offer high growth opportunities for players active in the global renal denervation systems market.
However, stringent regulatory guidelines for product approval in specific countries are expected to hamper the optimal market growth for renal denervation systems during the forecast period.
As of 2016, Medtronic, Plc. Boston Scientific Corporation, St. Jude Medical, Inc., ReCor Medical, Inc., Cordis Corporation, and Terumo Corporation are some of the key players present in global renal denervation systems market. Over the past three years, these companies adopted new product development and launches, collaborations, agreements, partnerships, and geographical expansions as their key business strategies to ensure their growth in this market.
Get online access to the report on the World's First Market Intelligence Cloud
Request Sample Scope of the Report
This research report categorizes renal denervation systems market into the following segments and subsegments:
Renal denervation systems Market, by Technology
- Ultrasound Ablation
- Radiofrequency Ablation
- Pharmacologic Ablation
- Microinfusion
Renal denervation systems Market, by Products
- Catheters
- Single Electrode Catheter
- Multi Electrode Catheter
- RF Generator
- Nerve modifying agents
Renal denervation systems Market, by Disease Application
- Hypertension
- Heart failure
- Diabetes
- Renal failure
- Other applications
Renal denervation systems Market, by End User
- Diagnostic Centers and Hospitals
- Research & academia
- Ambulatory Care Centers
Renal denervation systems Market, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
1.3.3 Years Considered for the Study
1.4 Currency
1.5 Research Limitations
1.6 Major Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.2.1.1 Bottom-Up Approach
2.2.1.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Major Market Drivers
5.2.2 Major Market Restraints
5.2.3 Key Growth Opportunities
5.2.4 Major Market Challenges
6 Renal Denervation Systems Market Value Data, By Technology, USD Million (2015-2022)*
6.1 Introduction
6.2 Ultrasound Ablation
6.3 Radiofrequency Ablation
6.4 Pharmacologic Ablation
6.5 Microinfusion
7 Renal Denervation Systems Market Value Data, By Products, USD Million (2015-2022)*
7.1 Introduction
7.2 Catheters
7.2.1 Single Electrode Catheter
7.2.2 Multi Electrode Catheter
7.3 RF Generator
7.4 Nerve Modifying Agents
8 Renal Denervation Systems Market Value Data, By Disease Application, USD Million (2015-2022)*
8.1 Introduction
8.2 Hypertension
8.3 Cardiac Disorders
8.4 Diabetes
8.5 Renal Failure
8.6 Other Applications
9 Renal Denervation Systems Market Value Data, By End User, USD Million (2015-2022)*
9.1 Introduction
9.2 Diagnostic Centers and Hospitals
9.3 Research & Academia
9.3 Ambulatory Care Centers
10 Renal Denervation Systems Market Value Data, By Region, USD Million (2015-2022)
10.1 Introduction
10.2 North America
10.3 Europe
10.4 Asia-Pacific
10.5 Rest of the World**
11 Competitive Landscape
11.1 Overview
11.2 Vendor Inclusion Criteria
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Competitive Benchmarking
11.4.1 Analysis of Product Portfolio of Major Players in the Market (25 Players)
11.4.2 Business Strategies Adopted By Major Players in the Market (25 Players)
11.5 Global Market Ranking Analysis (2016)
12 Company Profiles***
12.1 Introduction
12.1.1 Geographic Benchmarking
12.2 Medtronic Inc
12.2.1 Business Overview
12.2.2 Products Offered
12.2.3 Recent Developments (2014-2017)
12.3 Boston Scientific Corporation.
12.3.1 Business Overview
12.3.2 Products Offered
12.3.3 Recent Developments (2014-2017)
12.4 St. Jude Medical
12.4.1 Business Overview
12.4.2 Products Offered
12.4.3 Recent Developments (2014-2017)
12.5 Recor Medical, Inc.,
12.5.1 Business Overview
12.5.2 Products Offered
12.5.3 Recent Developments (2014-2017)
12.6 Cordis Corporation
12.6.1 Business Overview
12.6.2 Products Offered
12.6.3 Recent Developments (2014-2017)
12.7 Terumo Corporation
12.7.1 Business Overview
12.7.2 Products Offered
12.7.3 Recent Developments (2014-2017)
12.8 Mercator Medsystems, Inc
12.8.1 Business Overview
12.8.2 Products Offered
12.8.3 Recent Developments (2014-2017)
12.9 Kona Medical, Inc
12.9.1 Business Overview
12.9.2 Products Offered
12.9.3 Recent Developments (2014-2017)
12.10 Cardiosonic Ltd
12.10.1 Business Overview
12.10.2 Products Offered
12.10.3 Recent Developments (2014-2017)
12.11 Covidien PLC.
12.11.1 Business Overview
12.11.2 Products Offered
12.11.3 Recent Developments (2014-2017)
12.12 Ablative Solutions, Inc..
12.12.1 Business Overview
12.12.2 Products Offered
12.12.3 Recent Developments (2014-2017)
12.13 Renal Dynamics Limited.
12.13.1 Business Overview
12.13.2 Products Offered
12.13.3 Recent Developments (2014-2017)
12.14 Bioscience Webster Inc. .
12.14.1 Business Overview
12.14.2 Products Offered
12.14.3 Recent Developments (2014-2017)
12.15 Hansen Medical.
12.15.1 Business Overview
12.15.2 Products Offered
12.15.3 Recent Developments (2014-2017)
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
Growth opportunities and latent adjacency in Renal Denervation Systems Market